Search alternatives:
ns decrease » _ decrease (Expand Search), a decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
0 decrease » _ decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
05 0 » 0 0 (Expand Search), 01 0 (Expand Search)
ns decrease » _ decrease (Expand Search), a decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
0 decrease » _ decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
05 0 » 0 0 (Expand Search), 01 0 (Expand Search)
-
201
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
Published 2025“…The data represents mean values and standard deviation, n = 3. <b>Legends:</b> ns: non-significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.…”
-
202
The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties.
Published 2020“…(F) The GluN2B-C456Y mutation decreases the sensitivity to glycine. <i>n</i> = 4 oocytes for WT (EC<sub>50</sub> = 0.38 ± 0.017 μM) and 9 oocytes for C456Y (EC<sub>50</sub> = 1.13 ± 0.049 μM), **<i>P</i> = 0.007, Mann-Whitney. …”
-
203
-
204
Decreased phosphorylation of EIF2α underlies the impairment of arsenite-induced SG formation in LSM12-depleted cells.
Published 2020“…Data represent means ± SEM (<i>n</i> = 3). n.s., not significant; *<i>P</i> < 0.05, **<i>P</i> < 0.01, as determined by Student <i>t</i> test. …”
-
205
-
206
DataSheet_1_Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.docx
Published 2021“…</p>Results<p>ULT resulted in a mean (standard deviation) decrease in SU level (464.22 ± 110.21 μmol/L at baseline, 360.93 ± 91.66 μmol/L at the final visit, p <0.001) accompanied by a decrease in median (interquartile range) VFA [97.30 (81.15–118.55) at baseline, 90.90 (75.85–110.05) at the final visit, p < 0.001]. …”
-
207
-
208
Summary of trend results based on Mann-Kendall test and Sen’s slope estimator for the 34 weather stations (arranged according to administrative division, in bold) for the wet season (May to October), (<i>p</i> < 0.10 = *, <i>p</i> < 0.05 = **, <i>p</i> < 0.01 = ***,—sign indicates decreasing trend).
Published 2022“…<p>Summary of trend results based on Mann-Kendall test and Sen’s slope estimator for the 34 weather stations (arranged according to administrative division, in bold) for the wet season (May to October), (<i>p</i> < 0.10 = *, <i>p</i> < 0.05 = **, <i>p</i> < 0.01 = ***,—sign indicates decreasing trend).…”
-
209
-
210
-
211
-
212
-
213
Cation Disorder and Large Tetragonal Supercell Ordering in the Li-Rich Argyrodite Li<sub>7</sub>Zn<sub>0.5</sub>SiS<sub>6</sub>
Published 2022“…A tetragonal argyrodite with >7 mobile cations, Li<sub>7</sub>Zn<sub>0.5</sub>SiS<sub>6</sub>, is experimentally realized for the first time through solid state synthesis and exploration of the Li–Zn–Si–S phase diagram. …”
-
214
Cation Disorder and Large Tetragonal Supercell Ordering in the Li-Rich Argyrodite Li<sub>7</sub>Zn<sub>0.5</sub>SiS<sub>6</sub>
Published 2022“…A tetragonal argyrodite with >7 mobile cations, Li<sub>7</sub>Zn<sub>0.5</sub>SiS<sub>6</sub>, is experimentally realized for the first time through solid state synthesis and exploration of the Li–Zn–Si–S phase diagram. …”
-
215
Cation Disorder and Large Tetragonal Supercell Ordering in the Li-Rich Argyrodite Li<sub>7</sub>Zn<sub>0.5</sub>SiS<sub>6</sub>
Published 2022“…A tetragonal argyrodite with >7 mobile cations, Li<sub>7</sub>Zn<sub>0.5</sub>SiS<sub>6</sub>, is experimentally realized for the first time through solid state synthesis and exploration of the Li–Zn–Si–S phase diagram. …”
-
216
-
217
-
218
-
219
Efficacy and Safety of Topical Loteprednol Etaponate 0.5% and Topical Dexamethasone 0.1% in Post Cataract Surgery in Iraqi Patients. .csv
Published 2024“…</p><p dir="ltr"><b>Objectives:</b> This study compares the effect of <a href="" target="_blank">topical loteprednol etabonate 0.5% and dexamethasone 0.1% on intraocular pressure (IOP) in post-cataract surgery.…”
-
220